DarioHealth (DRIO) EPS (Weighted Average and Diluted) (2013 - 2026)

DarioHealth has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at $1.25 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 56.45% year-over-year to $1.25; the trailing twelve-month figure through Mar 2026 stood at $5.46 (down 44.0% YoY), and the FY2025 full-year result was $10.12, down 17.52% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $1.25, up from $1.07 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $4.91 in Q3 2024, with the low at $0.08 in Q2 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.18 across 5 years, with a median of $0.64 in 2022.
• Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) slumped 86.21% — and 2025, when it jumped 1335.0%.
• DarioHealth's EPS (Weighted Average and Diluted) stood at $0.52 in 2022, then fell by 21.15% to $0.41 in 2023, then soared by 360.98% to $1.89 in 2024, then tumbled by 43.39% to $1.07 in 2025, then increased by 16.82% to $1.25 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $1.25 (Q1 2026), $1.07 (Q4 2025), and $2.96 (Q3 2025), per Business Quant data.